{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif

Ophthalmologists' Perspectives on the Use of Lipid-Based Artificial Tears in Dry Eye Disease (DED)

Doctor's details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. What is your subspeciality within ophthalmology? *

  2. Are you affiliated with a research institution, private practice, or teaching institute? *

  3. How many patients with dry eye disease do you typically see in a month? *

  4. What is the severity of dry eye disease in the patients you consult?*
    5. Mild DE
    %
    Moderate DE
    %
    Severe DE
    %
    Total 100%
  5. Write treatment duration (in days) of artificial tear substitute in severity of dry eye disease as per your current clinical practice: *
    6. Mild dry eyes
    days
    Moderate dry eyes
    days
    Severe dry eyes
    days
  6. What type of dry eye disease do you most commonly see in your practice? *
    7. Aqueous deficient DE
    %
    Evaporative DE
    %
    Mixed Type DE
    %
    Hyperosmolar
    %
    Any Other
    %
  7. Write treatment duration (in days) of artificial tear substitute in type of dry eye disease as per your current clinical practice: *
    8. Aqueous deficient DE
    days
    Evaporative DE
    days
    Mixed Type DE
    days
    Hyperosmolar
    days
  8. What are most common etiology underlying DED you see in your clinical practice? Please name the conditions *
    		9.
  9. What are most common etiology underlying DED you see in your clinical practice? Please name the conditions*
    		10.
  10. It is important to differentiate between types of dry eye disease (e.g., aqueous deficient DED, evaporative DED, mixed, hyperosmolar) because the choice of artificial tear drops depends on this. How much do you agree with this statement? *

  11. How do you differentiate between aqueous deficient and evaporative dry eye disease in your practice? *

  12. Which investigations do you use to differentiate between aqueous deficient and evaporative dry eye disease in your practice? (Select all that apply) *

  13. Please help us understand your choice of ATS (Artificial tears substitute) for following conditions *
    14. Severity &Type of DE CMC HPMC Polyethylene Glycol+ Propylene Glycol Propylene Glycol 0.6% w/v HA 0.1%

  14. Currently available aqueous-based formulations are effective for managing both aqueous deficient and evaporative dry eye disease. How much do you agree with this statement? *

  15. Do you think lipid based artificial tears are required? *

  16. Lipid based artificial tears are required to treat: *

  17. Lipid-based formulations contain both lipid and aqueous components that not only hydrate but also stabilize the tear film, providing longer-lasting relief. Therefore, lipid-based formulations can be used in all types of dry eye disease (Aqueous Deficient, Evaporative, or Mixed Type).*

    18. Question: To what extent do you agree with the statement that lipid-based formulations can be used effectively in all types of dry eye disease (Aqueous Deficient, Evaporative, or Mixed Type)?

  18. Do you face any challenges while using lipid-based artificial tear solutions in your patients? (Select all that apply) *

  19. What are the patient related challenges in managing Evaporative Dry Eyes? *
  20. What are the in-clinic challenges in diagnosing and managing evaporative dry eyes? *
  21. How important is the cost of therapy when choosing treatment for dry eye diseases? *
  22. What percentage of your dry eye patients express concern about the cost of therapy? *

  23. Have you ever switched from an affordable branded generic to an innovator brand for dry eye therapy? If so, what factors influenced your decision? *
  24. Can you describe how the cost of dry eye treatment has influence your choice or use of therapy? *
  25. How important is the packaging quality of eye drop bottle in influencing your prescribing decision? *
  26. What improvement would you recommend in the current packaging of ophthalmic solution to enhance patient experience and compliance? *
  27. How does preservative free artificial tears compare with multi dose artificial tears eye drops in your practice? *
  28. In clinical practice, how do you compare the efficacy and safety of affordable branded generics versus innovator artificial tears for dry eye therapy? *

  29. What is the price range of innovator lubricants considered affordable for your patients? *
  30. How do you balance efficacy and affordability when recommending dry eye treatment to patients? *
  31. Kindly share the duration ( in months ) of treatment recommended for your Dry eye patients *
    32. Duration of Treatment in Days
    Molecule Mild Moderate Severe